| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.19 | 3e-05 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.14 | 0.0007 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.087 | 0.04 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.084 | 0.07 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.091 | 0.09 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.055 | 0.2 |